Custom Strategy Development, Deployment, and Support
Parallax works with professional money managers to build or modify investment programs to meet their needs. This includes trading strategies, equity screening procedures, hedge fund strategies, overlays, or spreads. Once an investment program is built and tested, we add it to our automation system, which runs redundantly in Seattle and Laramie every night to ensure on-time delivery. Parallax will become your R&D partner. We will be there each day to answer questions, work with managers, and even meet with your clients.
Case Study: Marque Millennium Capital Management
Wilfred J. Meckel II and Kenneth J. Garvey, who worked together at J. & W. Seligman since 1985, founded Marque Millennium Capital Management, a large-capitalization value equity manager. The firm was incorporated in Delaware on September 21, 1990 and registered with the U.S. Securities and Exchange Commission as an investment advisor under the Investment Advisors Act of 1940, on December 13, 1990. Mr. Meckel and Mr. Garvey founded Marque Millennium with the objective of providing institutional investors a blend of consistent investment analysis utilizing computers extensively, with a strict portfolio discipline. This approach yields investment decisions made in the ever more volatile equity markets of today that are objective and unemotional. Marque Millennium began managing its first domestic equity account for a US tax-exempt client in November 1990. Kris Kaufman and Doug Frick developed our quantitative research, which created the highly effective proprietary programs currently used in our investment process. They have built artificially intelligent financial screening algorithms based on both classical valuation methods and the tenets of Behavioral Finance. Kris is a former senior geophysicist for a Halliburton subsidiary, and Doug is a professional computer scientist. The firm offers a large-capitalization value equity product, and is planning to roll out an international product and a select US equity product later this year.
